 | Up a level |
Riener, R; Guidali, M; Keller, U; Duschau-Wicke, V; Klamroth, V; Nef, T (2011). Transferring ARMin to the clinics and industry. Topics in spinal cord injury rehabilitation, 17(1), pp. 54-59. St. Louis, Mo.: Land
Buse, JB; Rosenstock, J; Sesti, G; Schmidt, WE; Montanya, E; Brett, JH; Zychma, M; Blonde, L; Ahmed, A; Alvarsson, M; Anderson, C; Aoki, A; Aranko, S; Bailey, B; Barbonta, D; Baur, C; Bednarczyk-Kaluzny, M; Blevins, T; Blonde, L; Bode, B; ... (2009). Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet, 374(9683), pp. 39-47. London: Elsevier 10.1016/S0140-6736(09)60659-0
Schurter, Tina; König, Benjamin; Vichard, Emmanuelle; Gessel, Ev; Bonvin, R; Maier, Volker Gerhard; Keller, U; Kropf, R; Beyeler, Christine; Guttormsen, Sissel; Huwendiek, Sören (16 September 2016). Zentrale Erkenntnisse der Qualitätssicherung des schriftlichen Teils der Schweizer Schlussprüfung Humanmedizin nach 6 Jahren. In: Jahrestagung GMA. Abstractband. Bern. 14.-17.09.2016. 10.3205/16gma179
